A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies
Ahmed O. Hassan(Washington University in St. Louis), Michael Diamond(Washington University in St. Louis), Wafaa B. Alsoussi(Washington University in St. Louis), Swathi Shrihari(Washington University in St. Louis), Shamus P. Keeler(Washington University in St. Louis), Ali H. Ellebedy(Washington University in St. Louis), Julie M. Fox(National Institutes of Health), Larissa B. Thackray(Washington University in St. Louis), Michael J. Holtzman(Washington University in St. Louis), Tingting Lei(Washington University in St. Louis), James Brett Case(Washington University in St. Louis), Aaron J. Schmitz(Washington University in St. Louis), Stanley Perlman(University of Iowa), Rita E. Chen(Washington University in St. Louis), Daved H. Fremont(Washington University in St. Louis), Jackson S. Turner(Washington University in St. Louis), Suellen Greco(Washington University in St. Louis), Paul B. McCray(University of Iowa), Adam L. Bailey(University of Wisconsin–Madison), Broc T. McCune(Washington University in St. Louis), Emma S. Winkler(Washington University in St. Louis), Natasha M. Kafai(Washington University in St. Louis)
Cited by 578
Related Papers
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
|Seminars in Immunopathology|2017|2.7k
Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
|Cell Metabolism|2016|1.5k
Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group
|Journal of Virology|2013|1.3k
The continued threat of emerging flaviviruses
|Nature Microbiology|2020|1.1k